| 摘要 |
The invention provides novel beta<SUB>2 </SUB>adrenergic receptor agonist compounds. The invention also provides pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with beta<SUB>2 </SUB>adrenergic receptor activity, and processes and intermediates useful for preparing such compounds.
|
